# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000899923-21-000031
Filing Date
2021-04-15
Accepted
2021-04-15 07:05:26
Documents
54
Period of Report
2021-06-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2021proxystatement.htm | DEF 14A | 1053912
2 |  | auditandfincommitteechair1a.jpg | GRAPHIC | 10247
3 |  | auditandfingre4a.jpg | GRAPHIC | 9749
4 |  | auditcomm6a.jpg | GRAPHIC | 2116
5 |  | bd1a.jpg | GRAPHIC | 3195
6 |  | bdivandind1a.jpg | GRAPHIC | 34961
7 |  | cahccommittee3a.jpg | GRAPHIC | 12067
8 |  | cahccommitteechair1a.jpg | GRAPHIC | 11488
9 |  | chart-0ecbda5c6b79422d8121a.jpg | GRAPHIC | 36371
10 |  | chart-4626b21e28424ce0b601a.jpg | GRAPHIC | 67909
11 |  | chart-54f43e1ec9c040c0ab51a.jpg | GRAPHIC | 76294
12 |  | chart-71575b334a2942cabee1a.jpg | GRAPHIC | 116626
13 |  | chart-d4c5b55df8704bedb7d1a.jpg | GRAPHIC | 83336
14 |  | chart-f300ae7d6258448c9fa1a.jpg | GRAPHIC | 41872
15 |  | chip1a.jpg | GRAPHIC | 9699
16 |  | compcomm5a.jpg | GRAPHIC | 1625
17 |  | diag1a.jpg | GRAPHIC | 2795
18 |  | diaz1a.jpg | GRAPHIC | 13028
19 |  | dreis1a.jpg | GRAPHIC | 9436
20 |  | finan1a.jpg | GRAPHIC | 3277
21 |  | haas1a.jpg | GRAPHIC | 28861
22 |  | hart1a.jpg | GRAPHIC | 13021
23 |  | image1a.jpg | GRAPHIC | 42506
24 |  | image_21a.jpg | GRAPHIC | 2930
25 |  | ind1a.jpg | GRAPHIC | 2658
26 |  | kumar1a.jpg | GRAPHIC | 15502
27 |  | lambert1a.jpg | GRAPHIC | 12167
28 |  | lanch1a.jpg | GRAPHIC | 13014
29 |  | langer1a.jpg | GRAPHIC | 9448
30 |  | leader1a.jpg | GRAPHIC | 3315
31 |  | maggie1a.jpg | GRAPHIC | 12153
32 |  | myriadgeneticsinc1024_21.jpg | GRAPHIC | 121723
33 |  | myriadlogo1a.jpg | GRAPHIC | 25937
34 |  | newcomer1a.jpg | GRAPHIC | 8694
35 |  | nomandgovcommittee3a.jpg | GRAPHIC | 10781
36 |  | nomandgovcommitteechair1a.jpg | GRAPHIC | 11210
37 |  | nomcom5a.jpg | GRAPHIC | 2129
38 |  | paper1a.jpg | GRAPHIC | 8724
39 |  | paul_diazxwebsite-21a.jpg | GRAPHIC | 7429
40 |  | people1a.jpg | GRAPHIC | 8647
41 |  | phan1a.jpg | GRAPHIC | 9158
42 |  | phone1a.jpg | GRAPHIC | 8351
43 |  | proxycard-myriadgeneticsina.jpg | GRAPHIC | 104601
44 |  | pub1a.jpg | GRAPHIC | 2707
45 |  | randprodinv4a.jpg | GRAPHIC | 11150
46 |  | rea1a.jpg | GRAPHIC | 3176
47 |  | reitan1a.jpg | GRAPHIC | 8580
48 |  | researchcomm5a.jpg | GRAPHIC | 2016
49 |  | riggs1a.jpg | GRAPHIC | 12900
50 |  | santa21a.jpg | GRAPHIC | 28176
51 |  | skov1a.jpg | GRAPHIC | 11736
52 |  | spieg1a.jpg | GRAPHIC | 11559
53 |  | tech1a.jpg | GRAPHIC | 2462
54 |  | verr1a.jpg | GRAPHIC | 13719
| Complete submission text file | 0000899923-21-000031.txt |  | 2562560

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26642 | Film No.: 21827270
SIC: 2835 In Vitro & In Vivo Diagnostic Substances